"How many more people have to die?"
For Nandita and many others living with drug-resistant tuberculosis (DR-TB), a breakthrough drug called bedaquiline has meant the difference between life and death. Without access to bedaquiline, antiquated treatments for DR-TB can mean devastating side effects for TB survivors — Nandita lost her hearing after intensive treatment for her illness, including surgeries and daily injections. For half of those receiving treatment, this disease still remains a death sentence.
Johnson & Johnson, the pharmaceutical company who owns the patent for bedaquiline, is charging grossly inflated prices for it, keeping this lifesaving medicine out of the hands of those who need it. That’s why Doctors Without Borders/Médecins Sans Frontières (MSF) is demanding that Johnson & Johnson lower the price of bedaquiline to $1/day.
Help us save lives by making this drug affordable for everyone, now.